What can UK investors interested in Life Sciences learn from their more experienced, including US, counterparts?
The recent tie-up between Canary Wharf and Kadans demonstrates the enthusiasm of traditional UK RE investors and developers to access the lucrative life sciences market. By partnering with an experienced developer in the sector, Canary Wharf will benefit from in-depth sector knowledge gained by Kadans over many years of developing lab space, firstly overseas and more latterly in the UK market. So, what are the benefits to UK investors/developers looking to their overseas counterparts for guidance, best practice examples and a partnership to assist them in making the most of the opportunity that the growth in this market presents in the UK?
Whilst occupier demand is currently booming, and the life sciences sector is highly competitive to enter from a developer perspective. Not only is the land in the right location difficult to come by and expensive but building lab-capable space is much more expensive than an office building of the same internal area. Therefore, it is critical that the right decisions are made early on about how the buildings are designed and fitted out. An experienced life sciences developer or operator of laboratories already knows and understands the tenant market and the unique requirements of lab space. They see that re-purposing of existing stock is often a non-starter if the intention is for the building to be fitted as laboratories or at least “lab-capable” unless the fundamentals of the building already work.
Likewise, a life science developer knows how to design new buildings to make the best use of the available space. Any floors in the building will need a higher floor-to-ceiling height than an office would. Laboratories need increased utilities capacity to support all of the equipment likely to be required, including backup generators. Most lab spaces will need easy and secure access to chemical storage and sufficient loading bays and transport lifts. The experienced developer knows the types of equipment that will likely be needed by its eventual tenants, how much electricity they might use and what the tenant fit-out may look like. They may already know and work with an experienced team of professionals who know how to design and build the space.
A further benefit may be the existing relationships that an established life sciences developer has, perhaps in other areas of the country or even other jurisdictions. Life sciences is an international sector – you only have to look at the breadth of companies developing covid 19 vaccines to appreciate that.
Many established life sciences and pharmaceutical companies in the US, for example, will have little or no experience in the UK property market. This is where an established developer, perhaps in partnership with a UK entity, can add value to prospective tenants. Guiding them through the process of taking their first UK premises, from finding the right location, ensuring the premises are going to be suitable for the particular requirements of that tenant, making introductions to local professionals with sector knowledge and generally assisting with making a move to a new jurisdiction as smooth as possible.
From the perspective of the life sciences developer, why might they need their inexperienced UK counterpart? The simple answer may be that the UK entity has land and local market knowledge, perhaps including relationships with the all-important local planning authorities. A UK investor/developer with an established reputation and a track record of delivery may be favoured in competitive tender scenarios, which could be the difference between winning or losing a pitch.
It is going to be very interesting to see whether the Kadans and Canary Wharf partnership is a new model for life sciences development in the UK market. The opportunities in the market are clear for those that can combine the right sector development expertise with local knowledge and access to or existing ownership of land in the right location. The benefits to each side are clear, and we might expect to see more tie-ups like this in the coming months.
Written by Louise Ward.
An original version of this article was first published on EG on 16 May 2022. For more information, please contact Louise Ward or your usual Charles Russell Speechlys contact.
Our thinking
Claire Fallows
Politics, planning & life sciences clusters
David Coates
Charles Russell Speechlys advises Puma Private Equity on its investment into MUSO
We have advised long-term client Puma Private Equity on its investment into MUSO TNT Limited.
Emma Preece
Success for landlords as Court of Appeal dismiss cinema operators' appeal on COVID-19 arrears
Melania Constable
Melania Constable and Jessica Williams write for Pharmacy Business on what the collapse of Testerworld means for community pharmacies
What does the collapse of Testerworld mean for community pharmacies?
Mark Howard
IT Pro quotes Mark Howard on investment in UK tech start-ups
"The UK has the strongest venture and growth capital funding ecosystem in Europe.”
Christopher Hadnutt
Chris Hadnutt writes for Building Magazine on construction project defects
Chris Hadnutt writes for Building Magazine on construction project defects
Laura Bushaway
Are the Government’s plans to reform the leasehold and commonhold systems in England and Wales on a break?
Tristram van Lawick
The Sunday Times quotes Tristram van Lawick on investment into country estates
“For overseas buyers the security of the UK property market is seen as a safe investment compared with other parts of the world"
Nicola Saccardo
Charles Russell Speechlys welcomes Partner Nicola Saccardo to the Firm’s London office
Charles Russell Speechlys welcomes Partner Nicola Saccardo
Simon Ridpath
Charles Russell Speechlys announces 24% international revenue growth
Charles Russell Speechlys announces 24% international revenue growth
Michael Powner
Barrister with gender critical beliefs discriminated against by chambers
An employment tribunal has found that the barrister, Allison Bailey was discriminated against because of her gender critical beliefs.
Sarah Morley
The new UK register of overseas entities – the impact on property transactions
The Economic Crime Act establishes a new register of beneficial ownership of overseas entities, read the implications here.
Piers Master
Register of Overseas Entities: What are the deadlines for trust structures holding UK real estate?
The ROE is intended to launch on 1 August 2022 - read more about the deadlines trust structures holding UK real estate will be facing
Emma Preece
EG quotes Emma Preece on the Cine-UK and Cineworld Court of Appeal Covid rent arrears ruling
“This appeal was always going to be an uphill battle for the tenants.”
David Savage
Construction News quotes David Savage on a recent fire safety ruling and the implications of this
"Although clearly fact-specific as any case is, this is an interesting and important case..."
Sally Ashford
Changing an Enduring Power of Attorney
Learn what you need to know about changing an Enduring Power of Attorney to a Lasting Power of Attorney.
Rhys Novak
Charles Russell Speechlys helps defeat bribery prosecution in stunning victory in the Milan Court of Appeal
Charles Russell Speechlys victorious in the Milan Court of Appeal
Nick Hurley
The Guardian quotes Nick Hurley on the recent Supreme Court holiday pay ruling
"It is one of the few examples of a situation where a part time worker is treated more favourably than a full time worker..."
Darren Bailey
The Financial Times quotes Darren Bailey on the European Super League and the landmark case at the ECJ
“A win for the clubs may well lead to a far more fragmented football landscape"
Nic Couchman
Charles Russell Speechlys advises Fresh Air Festival on the Bangkok Century Cup 2022
Charles Russell Speechlys advises Fresh Air Festival on the Bangkok Century Cup 2022